SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-16-000914
Filing Date
2016-12-12
Accepted
2016-12-12 16:47:51
Documents
58
Period of Report
2016-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q peregrine_10q-103116.htm 10-Q 388299
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER peregrine_10q-ex3101.htm EX-31.1 8048
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER peregrine_10q-ex3102.htm EX-31.2 7986
4 CERTIFICATION peregrine_10q-ex32.htm EX-32 5285
  Complete submission text file 0001683168-16-000914.txt   2778472

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE pphm-20161031.xml EX-101.INS 574780
6 XBRL SCHEMA FILE pphm-20161031.xsd EX-101.SCH 28498
7 XBRL CALCULATION FILE pphm-20161031_cal.xml EX-101.CAL 48962
8 XBRL DEFINITION FILE pphm-20161031_def.xml EX-101.DEF 100571
9 XBRL LABEL FILE pphm-20161031_lab.xml EX-101.LAB 202091
10 XBRL PRESENTATION FILE pphm-20161031_pre.xml EX-101.PRE 183156
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 001-32839 | Film No.: 162046754
SIC: 2834 Pharmaceutical Preparations